During the differentiation process of glioma cells, the mature glial marker GFAP or the neural-specific transcriptional factors including DLX2, Brn3a and NeuroD6 [4], are up-regulated along with the specific morphological changes and weak proliferative and invasive capacity. The gene discussed is GFAP; the disease is central nervous system cancer.